Evidence map›Paper›PMID 37548804›Full record

Trial reportCardiovascular toxicology2023

Electronic Cigarette Vaping with Nicotine Causes Increased Thrombogenicity and Impaired Microvascular Function in Healthy Volunteers: A Randomised Clinical Trial.

Gustaf Lyytinen, Amelie Brynedal, Erik Anesäter, Lukasz Antoniewicz, Anders Blomberg, Håkan Wallén, Jenny A Bosson, Linnea Hedman, Fariborz Mobarrez, Sara Tehrani and 1 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cardiovascular toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04175457 (The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis), which is not on this map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04175457 nacompletednot on this map

The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis

TypeinterventionalSponsorKarolinska InstitutetRan2019 to 2020Enrolled22ConditionsE-cigarette Use, Microcirculation, Thrombosis, Vascular FunctionArmse-cigarette
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Gustaf LyytinenDepartment of Clinical Sciences, Division of Cardiovascular Medicine, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden. gustaf.lyytinen@ki.se.
Amelie BrynedalSection of Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Erik AnesäterDepartment of Clinical Sciences, Division of Cardiovascular Medicine, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.
Lukasz AntoniewiczDepartment of Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria.
Anders BlombergSection of Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Håkan WallénDepartment of Clinical Sciences, Division of Cardiovascular Medicine, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.
Jenny A BossonSection of Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Linnea HedmanSection of Sustainable Health, Department of Public Health and Clinical Medicine, The OLIN Unit, Umeå University, Umeå, Sweden.
Fariborz MobarrezDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Sara TehraniDepartment of Clinical Sciences, Division of Internal Medicine, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.
Magnus LundbäckDepartment of Clinical Sciences, Division of Cardiovascular Medicine, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.
Umeå University · SEKarolinska University Hospital · SEKarolinska Institutet · SEMedical University of Vienna · ATUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electronic cigarette (EC) vaping is increasingly popular, despite growing evidence of adverse health effects. To further evaluate the impact of EC use on vascular health, we investigated the effects of brief EC inhalation on flow-dependent thrombus formation and microcirculation in healthy volunteers. The study was performed with a randomised double-blind crossover design. Twenty-two healthy subjects aged between 18 and 45 years with occasional tobacco use were recruited. Subjects inhaled 30 puffs of EC aerosol with and without nicotine on two occasions separated by a wash-out period of at least 1 week. Blood samples were collected at baseline and at 15 and 60 min following exposure and analysed with the Total-Thrombus-formation analysis system evaluating fibrin-rich thrombus formation and platelet thrombus formation in whole blood under flow. Microvascular function was assessed at baseline and 30 min after exposure by laser speckle contrast imaging and iontophoresis of acetylcholine and sodium nitroprusside (SNP) to evaluate the endothelium-dependent and independent pathways of vasodilation. Compared with nicotine free EC aerosol, exposure to EC aerosol with nicotine significantly increased platelet thrombus formation and fibrin-rich thrombus formation at 15 min (p = 0.017 and p = 0.037, respectively) with normalisation after 60 min. Peak SNP-mediated microvascular perfusion, i.e. endothelium-independent vasodilation, was reduced following EC vaping with nicotine compared with baseline (p = 0.006). Thirty puffs of EC aerosol with nicotine increased platelet and fibrin-dependent thrombus formation and reduced microvascular dilatation capacity. No compelling effects of EC vaping without nicotine were observed, indicating nicotine as the main effector. Trial registration: ClinicalTrials.gov Identifier: NCT04175457 URL: https://clinicaltrials.gov/ct2/show/NCT04175457.

Indexed as

Electronic Nicotine Delivery SystemsVapingAdolescentAdultAerosolsFibrinHumansMiddle AgedNicotineYoung AdultAerosolsFibrinNicotineCoagulationE-cigaretteElectronic cigaretteMicrocirculationNicotinePlateletsThrombosis

Identifiers

PMID37548804
PMCPMC10435650
OpenAlexW4385620517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.